Head-to-head · WeighScore
Garcia Weight Loss, Aesthetics & Hormone Therapy vs GoodRx
The verdict
GoodRx takes it — 69.6/100 to 59.4/100.
GoodRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Garcia Weight Loss, Aesthetics & Hormone Therapy | GoodRx |
|---|---|---|
| WeighScore | 59.4/100 | 69.6/100 |
| Grade | C | C |
| Scorecard rank | #342 | #116 |
| Semaglutide | $400/mo (starting dose, compounded) | Not disclosed |
| Tirzepatide | Not disclosed | $299/mo (brand Zepbound) |
| Coverage | 1 state | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #342 · C
Strengths
- Established since 2000 with 4 Tampa Bay locations and 50,000+ patients treated
- GLP-1 program includes full metabolic and hormone lab panel
- Medication and supplies shipped directly to your door from partner pharmacy
- Free 15-minute consultation; both weekly-visit (Premier) and monthly-visit (Standard) tiers
- LegitScript transparency certification listed in footer
Where it loses points
- Florida only — 4 locations in Tampa Bay metro area only
- Pricing not publicly listed on website ($400/month per Facebook ad)
- Specific GLP-1 drug (semaglutide vs tirzepatide) not disclosed on site
- Telemedicine availability not confirmed on site despite Facebook ad claims
- In-person visit model less convenient than fully online telehealth providers
Graded #116 · C
Strengths
- $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
- $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
- Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
- No membership fee — bring your own prescription and present the discount card at the pharmacy counter
- Brand-name FDA-approved medication, not compounded
Where it loses points
- Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
- Self-pay only — does not apply toward insurance benefits or deductibles
- Headline price applies to the lowest Foundayo dose; higher doses may cost more
- No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
- Pricing can change as Lilly's manufacturer coupon program evolves
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.